What legislation monitors the use of products that can be used to produce methamphetamine, including specific limits on usage?

The Combat Methamphetamine Epidemic Act of 2005 was specifically designed to combat the growing abuse of methamphetamine by regulating the sale and distribution of precursor chemicals that can be used to produce the drug. It outlines strict limits on the amount of these substances that an individual can purchase within a certain time frame, making it more difficult for individuals to obtain the necessary ingredients for methamphetamine synthesis. The Act requires pharmacies and retailers to keep all products containing pseudoephedrine behind the counter, thereby enhancing monitoring and tracking of these products.

The Affordable Care Act, while significant in healthcare reform, does not pertain to drug enforcement or specific restrictions on substances used to make methamphetamine. The Dietary Supplement Health and Education Act focuses on dietary supplements and their regulation, unrelated to controlled substances. Similarly, the Medicare Prescription Drug Improvement Act deals with Medicare improvements rather than addressing issues related to methamphetamine production or sales regulation. Therefore, the Combat Methamphetamine Epidemic Act of 2005 is the appropriate legislation focused on controlling the substances linked to methamphetamine manufacturing.